Physicochemical characterisation of cationic polybutylcyanoacrylate-nanoparticles by fluorescence correlation spectroscopy.
暂无分享,去创建一个
A. Zimmer | M. Karas | J. Weyermann | D. Lochmann | Christiane Georgens | J. Kreuter | Isam Rais | M. Wolkenhauer
[1] P. Schwille,et al. Fluorescence correlation spectroscopy for the detection and study of single molecules in biology. , 2002, BioEssays : news and reviews in molecular, cellular and developmental biology.
[2] Y. Engelborghs,et al. Interactions Between Oligonucleotides and Cationic Polymers Investigated by fluorescence Correlation Spectroscopy , 2001, Pharmaceutical Research.
[3] E. Gratton,et al. Fluorescence Fluctuation Analysis for the Study of Interactions between Oligonucleotides and Polycationic Polymers , 2001, Biological chemistry.
[4] A. Zimmer,et al. Fluorescence Correlation Spectroscopy for the Characterisation of Drug Delivery Systems , 2001, Biological chemistry.
[5] I Lebedeva,et al. Cellular delivery of antisense oligonucleotides. , 2000, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[6] R. Pecora,et al. Dynamic Light Scattering Measurement of Nanometer Particles in Liquids , 2000 .
[7] A. Zimmer,et al. Enhanced antisense efficacy of oligonucleotides adsorbed to monomethylaminoethylmethacrylate methylmethacrylate copolymer nanoparticles. , 2000, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[8] A. Zimmer,et al. Evaluation of aminoalkylmethacrylate nanoparticles as colloidal drug carrier systems. Part II: characterization of antisense oligonucleotides loaded copolymer nanoparticles. , 1999, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[9] A. Zimmer,et al. Evaluation of aminoalkylmethacrylate nanoparticles as colloidal drug carrier systems. Part I: Synthesis of monomers, dependence of the physical properties on the polymerization methods. , 1999, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[10] M. Eigen,et al. Confocal fluorescence coincidence analysis: an approach to ultra high-throughput screening. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[11] P. Couvreur,et al. Biodegradable polyalkylcyanoacrylate nanoparticles for the delivery of oligonucleotides. , 1998, Journal of controlled release : official journal of the Controlled Release Society.
[12] M. Eigen,et al. Real-time enzyme kinetics monitored by dual-color fluorescence cross-correlation spectroscopy. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[13] A. Zimmer,et al. Cationic polyhexylcyanoacrylate nanoparticles as carriers for antisense oligonucleotides. , 1997, Antisense & nucleic acid drug development.
[14] D. Letourneur,et al. Synthesis and characterization of highly sensitive heparin probes for detection of heparin-binding proteins. , 1997, Analytical biochemistry.
[15] A. Zimmer,et al. Characterization of polybutyleyanoacrylate nanoparticles. Part II: Determination of polymer content by NMR-analysis , 1996 .
[16] Ausserer Wa,et al. High-resolution analysis and purification of synthetic oligonucleotides with strong anion-exchange HPLC. , 1995 .
[17] C. Hélène,et al. Antisense oligonucleotides adsorbed to polyalkylcyanoacrylate nanoparticles specifically inhibit mutated Ha-ras-mediated cell proliferation and tumorigenicity in nude mice. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[18] P. Couvreur,et al. Polyalkylcyanoacrylate Nanoparticles as Polymeric Carriers for Antisense Oligonucleotides , 1992, Pharmaceutical Research.
[19] A. Zimmer,et al. Use of liposomes, viral capsids, and nanoparticles as DNA carriers , 1991, Biotechnology and applied biochemistry.
[20] S. Davis,et al. Particle size and size distribution of poly(butyl-2-cyanoacrylate) nanoparticles: I. Influence of physicochemical factors , 1984 .
[21] B. Berne,et al. Dynamic Light Scattering: With Applications to Chemistry, Biology, and Physics , 1976 .
[22] R. M. Fitch. The homogeneous nucleation of polymer colloids , 1973 .
[23] R. M. Fitch,et al. Polymer colloids: Particle formation in nonmicellar systems , 1970 .
[24] I Lebedeva,et al. Antisense oligonucleotides: promise and reality. , 2001, Annual review of pharmacology and toxicology.
[25] Villejuif,et al. Pharmaceutical Aspects of Oligonucleotides , 2000 .
[26] D. Letourneur,et al. Antiproliferative capacity of synthetic dextrans on smooth muscle cell growth: the model of derivatized dextrans as heparin-like polymers. , 1993, Journal of biomaterials science. Polymer edition.
[27] S. Davis,et al. Poly(butyl 2-cyanoacrylate) nanoparticles with differing surface charges , 1986 .
[28] R. Pecora. Dynamic Light Scattering , 1985 .
[29] S. Davis,et al. Particle size and size distribution of poly(butyl 2-cyanoacrylate) nanoparticles. II. Influence of stabilizers , 1985 .
[30] J Kreuter,et al. Evaluation of nanoparticles as drug-delivery systems. III: materials, stability, toxicity, possibilities of targeting, and use. , 1983, Pharmaceutica acta Helvetiae.
[31] M. Stephenson,et al. Inhibition of Rous sarcoma viral RNA translation by a specific oligodeoxyribonucleotide. , 1978, Proceedings of the National Academy of Sciences of the United States of America.
[32] M. Stephenson,et al. Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide. , 1978, Proceedings of the National Academy of Sciences of the United States of America.